Diagnosis of Hyperacute and Acute Ischaemic Stroke: The Potential Utility of Exosomal MicroRNA-21-5p and MicroRNA-30a-5p
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background: Early and accurate diagnosis of ischaemic stroke (IS) requires the use of an optimized biomarker. Exosomal microRNAs have the potential to serve as biomarkers owing to their stability and specificity. We investigated the expression levels of plasma-derived exosomal microRNA-21-5p and microRNA-30a-5p in the different phases of IS. Methods: One hundred forty-three patients with IS and 24 non-stroke controls were enrolled. The patients were divided into the following 5 groups: 1 group for the hyperacute phase IS (HIS, within 6 h); two for the acute phase IS (AIS, including days 1–3 and days 4–7); one for the subacute phase IS (SIS, days 8–14); and one for the recovery phase IS (RIS, days >14). Plasma exosomes were isolated using a QIAGEN exoRNeasy kit and examined by transmission electron microscopy, nanoparticle tracking, and flow cytometry. The expression levels of miRNA-21-5p and miRNA-30a-5p were detected by quantitative real-time polymerase chain reaction. Results: The plasma exosomal miR-21-5p levels in SIS and RIS were significantly higher than that in controls (p < 0.05 and p < 0.01 respectively). The levels of miR-30a-5p in HIS were significantly higher (p < 0.05) and in AIS (days 1–3) were lower than that in controls (p < 0.05). In AIS (days 1–3), both miRNAs were decreased compared with the HIS group (p = 0.053 and 0.001, respectively). The area under the curve (AUC) of the miR-21-5p was 0.714 for SIS (95% CI 0.570–0.859, p = 0.007), 0.734 for RIS (95% CI 0.596–0.871, p = 0.003); the AUC of the miR-30a-5p was 0.826 for HIS (95% CI 0.665–0.988, p = 0.001), 0.438 for AIS (days 1–3; 95% CI 0.240–0.635, p = 0.516). Conclusions: The plasma-derived exosomal miR-21-5p and miRNA-30a-5p in combination are promising biomarkers for diagnosing IS and distinguishing among HIS, SIS, and RIS, especially miRNA-30a-5p for the diagnosis of the HIS phase. Our results provide a new reference for clinicians to apply in early-stage diagnosis and identifies the possible value of biomarkers for IS thrombolysis therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Circulating EVs have proven to be valuable biomarkers for the early, noninvasive diagnosis of ischemic stroke [301–304].”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [304]
In the citing paper
“Our data also showed the overexpression of miRNA-21-3p and miRNA-30a-5p (Wang et al., 2018), but they did not reach the significance threshold.”
From Acute Cerebral Ischemia Increases a Set of Brain-Specific miRNAs in Serum Small Extracellular Vesicles (2022) · cites this paper as Wang et al., 2018
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Adams, H. P., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. E. (1993) · Stroke · doi:10.1161/01.str.24.1.35 · Cited by 12,335
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Self-citationCommunication by Extracellular Vesicles: Where We Are and Where We Need to Go
Tkach, M., & Théry, C. (2016) · Cell · doi:10.1016/j.cell.2016.01.043 · Cited by 3,444
Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., Mitchell, P. S., Bennett, C. F., Pogosova-Agadjanyan, E. L., Stirewalt, D. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019055108 · Cited by 3,294
The MicroRNA Spectrum in 12 Body Fluids
Weber, J. A., Baxter, D. H., Zhang, S., Huang, D. Y., How Huang, K., Jen Lee, M., Galas, D. J., & Wang, K. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.147405 · Cited by 2,477
Exosomal-like vesicles are present in human blood plasma
Caby, M.-P., Lankar, D., Vincendeau-Scherrer, C., Raposo, G., & Bonnerot, C. (2005) · International Immunology · doi:10.1093/intimm/dxh267 · Cited by 1,343
Acute Stroke Intervention: A Systematic Review
Prabhakaran, S., Ruff, I., & Bernstein, R. A. (2015) · JAMA · doi:10.1001/jama.2015.3058 · Cited by 671
Cited by
Role of Exosomes in Central Nervous System Diseases
Liu, W., Bai, X., Zhang, A., Huang, J., Xu, S., & Zhang, J. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00240 · Cited by 221
Circulating microRNAs: Biomarkers of disease
Wu, Y., Li, Q., Zhang, R., Dai, X., Chen, W., & Xing, D. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.008 · Cited by 178
Role of exosomes in the pathogenesis, diagnosis, and treatment of central nervous system diseases
Fan, Y., Chen, Z., & Zhang, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03493-6 · Cited by 134
Emerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury
Feng, J., Zhang, Y., Zhu, Z., Gu, C., Waqas, A., & Chen, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.703989 · Cited by 106
Rahmani, A., Saleki, K., Javanmehr, N., Khodaparast, J., Saadat, P., & Nouri, H. R. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101106 · Cited by 98
Shetgaonkar, G. G., Marques, S. M., DCruz, C. E. M., Vibhavari, R. J. A., Kumar, L., & Shirodkar, R. K. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01026-0 · Cited by 400
Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope?
Crigna, A. T., Samec, M., Koklesová, L., Líšková, A., Giordano, F. A., Kubatka, P., & Golubnitschaja, O. (2020) · The EPMA Journal · doi:10.1007/s13167-020-00226-x · Cited by 81
Exosome-mediated delivery and regulation in neurological disease progression
Singh, G., Mehra, A., Arora, S., Gugulothu, D. B., Vora, L. K., Prasad, R., & Khatri, D. K. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130728 · Cited by 90
Potential of Exosomes for the Treatment of Stroke
Hong, S., Yang, H., Manaenko, A., Lu, J., Mei, Q., & Hu, Q. (2018) · Cell Transplantation · doi:10.1177/0963689718816990 · Cited by 83
Hermann, D. M., Xin, W., Bähr, M., Giebel, B., & Doeppner, T. R. (2022) · Theranostics · doi:10.7150/thno.73931 · Cited by 83
Therapeutic application of exosomes in ischaemic stroke
Li, Y., Tang, Y., & Yang, G.-Y. (2021) · Stroke and Vascular Neurology · doi:10.1136/svn-2020-000419 · Cited by 71
Xu, X., Iqbal, Z., Xu, L., Wen, C., Duan, L., Xia, J., Yang, N., Zhang, Y., & Liang, Y. (2024) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13610 · Cited by 68
Function of exosomes in neurological disorders and brain tumors
Xiao, L., Hareendran, S., & Loh, Y. P. (2021) · Extracellular Vesicles and Circulating Nucleic Acids · doi:10.20517/evcna.2021.04 · Cited by 77
Diagnostic and Therapeutic Potential of Exosomes in Neurodegenerative Diseases
Gao, P., Li, X., Du, X., Liu, S., & Xu, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.790863 · Cited by 60
Wang, Z., Wen, Z.-J., Xu, H.-M., Zhang, Y., & Zhang, Y.-F. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1004221 · Cited by 65
Bulygin, K. V., Beeraka, N. M., Saitgareeva, A. R., Nikolenko, V. N., Фанилевич, Г. И., Beylerli, O., Ахмадеева, Л. Р., Михалева, Л. М., Solis, L. F. T., Herrera, A. S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186728 · Cited by 65
Potential Role of Exosomes in Ischemic Stroke Treatment
Jiang, L., Chen, W., Ye, J., & Wang, Y. (2022) · Biomolecules · doi:10.3390/biom12010115 · Cited by 62
Xu, Y., Hu, Y., Xu, S., Liu, F., & Gao, Y. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.747380 · Cited by 65
Khan, N. A., Asim, M., El-Menyar, A. A., Biswas, K. H., Rizoli, S. B., & Al-Thani, H. A. S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.933434 · Cited by 59
Haupt, M., Zheng, X., Kuang, Y., Lieschke, S., Janssen, L., Bosche, B., Jin, F., Hein, K., Kılıç, E., Venkataramani, V., et al. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0086 · Cited by 54
The role of exosomal microRNAs in central nervous system diseases
Yu, Y., Hou, K., Ji, T., Wang, X., Liu, Y., Zheng, Y., Xu, J., Hou, Y., & Chi, G. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04053-0 · Cited by 59
Altered Extracellular Vesicle MicroRNA Expression in Ischemic Stroke and Small Vessel Disease.
van Kralingen, J. C., McFall, A., Ord, E. N. J., Coyle, T. F., Bissett, M., McClure, J. D., McCabe, C., Macrae, I. M., Dawson, J., & Work, L. M. (2019) · Translational Stroke Research · doi:10.1007/s12975-018-0682-3 · Cited by 47
Qi, Z., Zhao, Y., Su, Y., Cao, B., Yang, J.-J., & Xing, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.685088 · Cited by 44
“miR-21-5p and miR-30a-5p were highly expressed in AIS but decreased in the subacute phase (Wang et al., 2018).”
BackgroundForró, T., Bajkó, Z., Bălașa, A. F., & Bălașa, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115621 · Cited by 52
Exosomal microRNA and stroke: A review
Ghoreishi, A., Khosravi, A., & Ghaemmaghami, A. B. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29130 · Cited by 43
Identification of Novel Circulating miRNAs in Patients with Acute Ischemic Stroke
Al‐Dous, E., Toor, S. M., Parray, A., Al-Sarraj, Y. A., Diboun, I., Abdelalim, E. M., Arredouani, A., El‐Agnaf, O. M. A., Thornalley, P. J., Akhtar, N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063387 · Cited by 38
Extracellular Vesicles in Acute Stroke Diagnostics
Stenz, K. T., Just, J., Blauenfeldt, R. A., & Drasbek, K. R. (2020) · Biomedicines · doi:10.3390/biomedicines8080248 · Cited by 36
Pan, Y., Liu, Y., Wei, W., Yang, X., Wang, Z., & Xin, W. (2023) · Small · doi:10.1002/smll.202205739 · Cited by 37
Advances in the detection of biomarkers for ischemic stroke
Liang, Y., Chen, J., Chen, Y., Tong, Y., Li, L., Xu, Y. X., & Wu, S. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1488726 · Cited by 30
Mesenchymal stem cell‐derived exosomes: Shaping the next era of stroke treatment
Waseem, A., Saudamini, Haque, R., Janowski, M., & Raza, S. S. (2023) · Neuroprotection/Neuroprotection (Chichester, England. Print) · doi:10.1002/nep3.30 · Cited by 31
Systematic review: Association between circulating microRNA expression & stroke
Fullerton, J. L., Thomas, J. M., Gonzalez-Trueba, L., Trivett, C., van Kralingen, J. C., Allan, S. M., Quinn, T. J., & Work, L. M. (2022) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x221085090 · Cited by 29
Xie, Y., Chen, B., Wang, Q., Chen, X., Lai, W., Xu, Y., Deng, S., Yu, Z., Xie, M., Bu, B.-T., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26650 · Cited by 29
Self-citationJiang, H., Zhang, C., Lin, M., Yin, Y., Deng, S., Liu, W., Zhuo, B., Tian, G., Du, Y., & Meng, Z. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102536 · Cited by 37
Wei, W., Pan, Y., Yang, X., Chen, Z., Heng, Y., Yang, B., Pu, M., Zuo, J., Lai, Z., Tang, Y., et al. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s362865 · Cited by 29
Zarà, M., Campodonico, J., Cosentino, N., Biondi, M. L., Amadio, P., Milanesi, G., Assanelli, E. M., Cerri, S., Biggiogera, M., Sandrini, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158065 · Cited by 30
Exosomes-based therapy of stroke, an emerging approach toward recovery
Seyedaghamiri, F., Salimi, L., Ghaznavi, D., Sokullu, E., & Rahbarghazi, R. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00919-y · Cited by 33
Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions
Choi, H. K., Chen, M., Goldston, L. L., & Lee, K.-B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00426-5 · Cited by 26
Extracellular Vesicle Application as a Novel Therapeutic Strategy for Ischemic Stroke
Li, Y., Liu, B., Chen, Y., Quan, X., Han, Y., Zheng, Y., & Zhao, Y. (2021) · Translational Stroke Research · doi:10.1007/s12975-021-00915-3 · Cited by 26
Hosoki, S., Tanaka, T., & Ihara, M. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105015 · Cited by 29
Xin, W., Qin, Y., Lei, P., Zhang, J., Yang, X., & Wang, Z. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.08.032 · Cited by 27
Circulating Exosomes of Neuronal Origin as Potential Early Biomarkers for Development of Stroke
Yousif, G., Qadri, S. M., Haik, M. Y., Haik, Y., Parray, A., & Shuaib, A. M. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00508-0 · Cited by 27
Liu, W., Jin, M., Chen, Q., Li, Q., Xing, X., Luo, Y., & Sun, X. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01304-z · Cited by 23
Wang, X., Zhou, H., Cheng, R., Zhou, X., Hou, X., Chen, J., & Qiu, J. (2020) · Molecular Brain · doi:10.1186/s13041-020-00579-4 · Cited by 21
Self-citationCirculating Exosomes and Their Role in Stroke
Esfehani, R. J., Soudyab, M., Parizadeh, S. M., Jaripoor, M. E., Sasannejad, P., Shariati, M., & Nabavi, A. S. (2019) · Current Drug Targets · doi:10.2174/1389450120666190821153557 · Cited by 25
MicroRNAs as sentinels and protagonists of carotid artery thromboembolism
Raju, S., Fish, J. E., & Howe, K. L. (2020) · Clinical Science · doi:10.1042/cs20190651 · Cited by 23
Monteiro-Reis, S., Carvalho-Maia, C., Bart, G., Vainio, S. J., Pedro, J., Silva, E. R., Sales, G., Henrique, R., & Jerónimo, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063267 · Cited by 21
Chiang, C.-S., Fu, S.-J., Hsu, C., Jeng, C., Tang, C., Huang, Y., & Tang, S. (2021) · NeuroMolecular Medicine · doi:10.1007/s12017-020-08641-z · Cited by 20
Exosomes in pathogenesis, diagnosis, and therapy of ischemic stroke
Jin, M., Zhang, S., Wang, M., Li, Q., Ren, J., Luo, Y., & Sun, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.980548 · Cited by 21
Reymond, S., Vujić, T., & Sanchez, J. (2022) · Biomedicines · doi:10.3390/biomedicines10092147 · Cited by 22
Jiang, W., Shi, X., Sun, L., Zhang, Y., Kong, X., Yang, X., Yin, Y., Li, C., & Li, X. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.83170 · Cited by 20
Florijn, B. W., van der Bent, M. L., Nguyen, T. M., Quax, P. H. A., Wermer, M. J. H., Nossent, A. Y., & Kruyt, N. D. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107388 · Cited by 19
Figueiredo, S., & Devezas, M. (2024) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2024.100401 · Cited by 23
Popescu-Drigă, M. V., Cătălin, B., Olaru, D. G., Słowik, A., Plesnila, N., Hermann, D. M., & Popa‐Wagner, A. (2021) · Biomedicines · doi:10.3390/biomedicines9091226 · Cited by 21
Extracellular vesicles and their microRNA cargo in ischaemic stroke
Fullerton, J. L., Cosgrove, C. C., Rooney, R. A., & Work, L. M. (2022) · The Journal of Physiology · doi:10.1113/jp282050 · Cited by 21
Szwed, K. A., Szwed, M., Kozakiewicz, M., Karłowska-Pik, J., Soja-Kukieła, N., Bartoszewska, A., & Borkowska, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143091 · Cited by 18
Fluid biomarkers in stroke: From animal models to clinical care
Dias, A., Silva, L., Moura, J., Gabriel, D., & Maia, L. F. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13668 · Cited by 18
Gao, X., Liu, D., Yue, K., Zhang, Z., Jiang, X., & Luo, P. (2024) · Biomolecules · doi:10.3390/biom14030378 · Cited by 23
Tang, X., He, Y., Liu, J., Xu, J., & Peng, Q. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113938 · Cited by 17
Self-citationEyileten, C., Czajka, P., Domitrz, I., Wierzchowska‐Ciok, A., Gąsecka, A., Mirowska-Guzel, D. M., Członkowska, A., & Postula, M. A. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01551-3 · Cited by 19
Wang, Y., Yu, L., & Wang, T. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.09.93 · Cited by 15
Li, T., Wan, W., Qin, Z., Chen, Y. E., Zhu, K., Liu, H., Sun, J., & Zhong, H. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1666589 · Cited by 17
The role of microRNAs as super-early biomarkers in acute ischemic stroke: A systematic review
Loggini, A., Hornik, J., & Hornik, A. (2024) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2024.108416 · Cited by 16
Zhou, X., Xu, C., Chao, D., Chen, Z., Li, S., Shi, M., Pei, Y., Dai, Y., Ji, J., Ji, Y., et al. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.874903 · Cited by 13
Self-citationAdvances in the diagnosis of exosomal miRNAs in ischemic stroke
Yu, P., & Chen, W. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s216784 · Cited by 16
Bioengineering exosomes for treatment of organ ischemia-reperfusion injury
Toghiani, R., Abolmaali, S. S., Najafi, H., & Tamaddon, A. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120654 · Cited by 12
Wei, D., Li, F., Guo, C., Chen, J., & You, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1601843 · Cited by 19
Zaman, A., Drake, S., & Fournier, A. E. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70323 · Cited by 19
Exosomal miRNAs as Biomarkers of Ischemic Stroke
Ciaccio, A. M., & Tuttolomondo, A. (2023) · Brain Sciences · doi:10.3390/brainsci13121647 · Cited by 15
Yao, Y., Fang, X., Yuan, J., Qin, F., Yu, T., Xia, D., Li, Z., & Lai, N. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s304394 · Cited by 15
Huang, L., Luo, Y., Xu, J., & Lu, Q.-C. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.584828 · Cited by 14
Blood-brain barrier repair: potential and challenges of stem cells and exosomes in stroke treatment
Fu, X., Li, J., Yang, S., Jing, J., Zheng, Q., Zhang, T., & Xu, Z. F. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1536028 · Cited by 11
Self-citationExosomes as biomarkers and therapeutic measures for ischemic stroke
Shi, Y., Wang, R., Wang, L., Liu, Q., Han, L., Duan, X., Zhang, Y., Shen, A.-Z., Peng, D., Chen, W., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175477 · Cited by 10
Expansion of plasma MicroRNAs over the first month following human stroke
Edwardson, M. A., Shivapurkar, N., Li, J., Khan, M., Smith, J., Giannetti, M. L., Fan, R., & Dromerick, A. W. (2023) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x231196982 · Cited by 10
Self-citationConsidering Context-Specific microRNAs in Ischemic Stroke with Three “W”: Where, When, and What
Chang, C., Wang, Y., Wang, R., & Bao, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04051-5 · Cited by 10
Sič, A., Atanasković, M., Ahmed, A., Petrović, I., Simović, F., Burnjaković, B., Tonković, U., Manzar, A., Shadab, S., Gajić, S., et al. (2025) · Medical Sciences · doi:10.3390/medsci13030172 · Cited by 14
Zhu, Y., Fang, X., Zhang, S., Liao, Y., Lin, H., Chen, P., Yang, M., Huang, J. J., & Wang, X. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s589123 · Cited by 17
Zhan, L., Pang, Y., Jiang, H., Zhang, S., Jin, H., Chen, J., Jia, C., Guo, H.-Y., & Mu, Z. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/4687349 · Cited by 9
RetractedZhang, X., Cai, Y., Sit, B. H. M., Jian, R. X., Malki, Y., Zhang, Y., Ong, C. C. Y., Li, Q., Lam, R. P. K., & Rainer, T. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041530 · Cited by 9
Exosomes in Post-Ischemic Brain
Pluta, R. M., & Jabłoński, M. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.cerebralischemia.2021.exosomes · Cited by 8
Zhang, C., Liu, Y., Bai, T., Shao, H., Xiong, Z., Epstein, M. M., Li, X., & Chen, H. (2025) · Biotechnology Advances · doi:10.1016/j.biotechadv.2025.108637 · Cited by 9
Saghazadeh, A., & Rezaei, N. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109205 · Cited by 8
Hu, J., Zhou, Z., Yang, Q., & Yang, K. (2020) · 南方医科大学学报 · doi:10.12122/j.issn.1673-4254.2020.07.02 · Cited by 7
Chang, C., Wang, Y., Liang, X., Wang, R., & Bao, X. (2025) · MedComm · doi:10.1002/mco2.70400 · Cited by 6
Roy, A., Driscoll, T. P., Grant, S. C., & Li, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110550 · Cited by 5
“Time Is Brain” – for Cell Therapies
Yin, H. R., Brian, D., Weber, R., Lyden, P. D., & Rust, R. (2025) · Advanced Science · doi:10.1002/advs.202519579 · Cited by 7
Smothers, C. G., Gandhi, S., Chang, J. H., Tahir, S. M., Kelley, J., Wang, E. Q., Fareed, K., Mack, H., Dong, C., Witort, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-71329-8 · Cited by 5
Wang, M., Zhang, B., Jin, F., Li, G., Cui, C., & Feng, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32022 · Cited by 6
RetractedExosomes in stroke management: A promising paradigm shift in stroke therapy
Wang, B., Chen, P., Li, W., & Chen, Z. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00665 · Cited by 6
Functional Roles of Mesenchymal Stem Cell-derived Exosomes in Ischemic Stroke Treatment
Farzaneh, M., & Khoshnam, S. E. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666221222123818 · Cited by 6
Role of Circulating Exosomes in Cerebrovascular Diseases: A Comprehensive Review
Lu, Z., Tang, H., Li, S., Zhu, S., Li, S., & Huang, Q. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230214112408 · Cited by 8
Identification of hypoxia- and immune-related biomarkers in patients with ischemic stroke
Zhang, H., Sun, J., Zou, P., Huang, Y., Yang, Q.-Z., Zhang, Z., Luo, P., & Jiang, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25866 · Cited by 6
Stroke biomarkers: Issues of diagnosis and medical rehabilitation
Ponomarev, G. V., Polyakova, A. V., Prokhorova, M. V., & Voznjouk, I. A. (2022) · Physical and rehabilitation medicine medical rehabilitation · doi:10.36425/rehab111899 · Cited by 5
Post-stroke Depression: Genetics, Mechanisms, and Treatment
Popa‐Wagner, A., Udriștoiu, I., Greșiță, A., Lledós, M., & Fernández‐Cadenas, I. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_434 · Cited by 4
Identification of diagnostic signatures for ischemic stroke by machine learning algorithm
Li, Q., Tian, Y., Niu, J., Guo, E., Lu, Y., Dang, C., Feng, L., Li, L., & Wang, L. (2024) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2024.107564 · Cited by 4
Abdelfattah‐Hassan, A., & Ibrahim, D. (2022) · Springer eBooks · doi:10.1007/978-981-16-8562-0_10 · Cited by 4
Xiao, X., Zhi, L., Peng, M., Yan, H., Yi, D., Du, Z., & Ji, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35201 · Cited by 3
Gan, J., Yang, X., Wu, J., Cai, Z., Zhai, X., Wu, Y., Li, W., & Wu, M. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01718-6 · Cited by 3
Wang, X., Wang, T., Zhu, D., Wang, J., & Han, W. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae105 · Cited by 3
MicroRNAs as Potential Diagnostic, Prognostic, and Therapeutic Biomarkers in Ischemic Stroke
Rajanikant, G. K., Gressèns, P., Nampoothiri, S. S., Surendran, G., & Bokobza, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-4798-0_7 · Cited by 2
Editorial: Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
Uphaus, T., Audebert, H. J., Graner, M. W., Tiedt, S., & Kowalski, R. G. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.866166 · Cited by 2
Metadata
- Authors
- Wang, W., Li, D.-B., Li, R.-Y., Zhou, X., Yu, D.-J., Lan, X.-Y., Li, J.-P., & Liu, J.-L.
- Affiliations
- Guangxi Medical University (CN)
- Venue
- Cerebrovascular Diseases
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 45
- Issue
- 5-6
- Pages
- 204-212
- ISSN
- 1015-9770 (ISSN-L)
- 1421-9786
- OpenAlex
- W2795447768
- Cited by
- 113
- References
- 48
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 16 · 2023: 11 · 2022: 25 · 2021: 23 · 2020: 12 · 2019: 5 · 2018: 2
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cerebrovascular Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- ischemic stroke, hyperacute stroke, acute stroke, exosomal microRNAs, miR-21-5p, miR-30a-5p, plasma exosomes, stroke biomarkers, subacute stroke, diagnostic accuracy, blood-based biomarkers, exosome isolation and characterization, nanoparticle tracking analysis, flow cytometry, transmission electron microscopy
- MeSH terms
- Aged, Brain Ischemia, Female, Genetic Markers, Humans, Male, Middle Aged, Predictive Value of Tests, Time Factors, Down-Regulation, Case-Control Studies, Stroke, MicroRNAs, Microscopy, Electron, Transmission, Exosomes, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.